The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Omnicare Inc

NYSE: OCR
Last

(U.S.) $70.63

Today's change+0.32 +0.46%
Updated November 21 4:04 PM EST. Delayed by at least 15 minutes.
 

Omnicare Inc

NYSE: OCR
Last

(U.S.) $70.63

Today's change+0.32 +0.46%
Updated November 21 4:04 PM EST. Delayed by at least 15 minutes.

Omnicare Inc up (U.S.)$0.32

Omnicare Inc closed up Friday by (U.S.)$0.32 or 0.46% to (U.S.)$70.63. Over the last five days, shares have gained 0.80% and are currently 1.23% off of the 52-week high. Shares have outperformed the S&P 500 by 8.30% during the last year.

Key company metrics

  • Open(U.S.) $70.93
  • Previous close(U.S.) $70.31
  • High(U.S.) $71.16
  • Low(U.S.) $70.48
  • Bid / Ask-- / --
  • YTD % change+17.01%
  • Volume881,845
  • Average volume (10-day)1,403,819
  • Average volume (1-month)1,423,801
  • Average volume (3-month)1,057,627
  • 52-week range(U.S.) $56.41 to (U.S.) $71.51
  • Beta1.29
  • Trailing P/E31.72×
  • P/E 1 year forward19.04×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.80
  • Dividend yield1.13%
  • Trailing EPS(U.S.) $2.23
Updated November 21 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.88%

Based on its net profit margin of 3.88%, Omnicare Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.24%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,6081,6111,5711,337
Total other revenue--------
Total revenue1,6081,6111,5711,337
Gross profit351354358302
Total cost of revenue1,2571,2561,2131,036
Total operating expense1,4721,4801,4381,217
Selling / general / administrative199205208180
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1719171
Other operating expenses, total--------
Operating income136130133121
Interest income (expense), net non-operating-29-30-29-30
Gain (loss) on sale of assets--------
Other--------
Income before tax10710010391
Income after tax68616445
Income tax, total39394046
Net income652264-84
Total adjustments to net income--------
Net income before extra. items68616445
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items68616445
Inc. avail. to common incl. extra. items652264-84
Diluted net income652264-83
Dilution adjustment0000
Diluted weighted average shares106106108109
Diluted EPS excluding extraordinary itemsvalue per share0.650.580.590.41
Dividends per sharevalue per share0.200.200.200.20
Diluted normalized EPSvalue per share0.750.690.690.42